- LGND Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Ligand Pharmaceuticals (LGND) 10-K/A2015 FY Annual report (amended)
Filed: 14 Nov 16, 12:00am
Name | Jurisdiction of Incorporation | |
Glycomed Incorporated | California | |
Allergan Ligand Retinoid Therapeutics, Inc. | Delaware | |
Ligand Pharmaceuticals International, Inc. | Delaware | |
Ligand Biopharmaceuticals, Incorporated | Delaware | |
Ligand JVR, Inc. | Delaware | |
Seragen Incorporated | Delaware | |
Seragen Technology, Inc. | Delaware | |
Pharmacopeia, LLC | Delaware | |
Metabasis Therapeutics, Inc. | Delaware | |
Neurogen Corporation | Delaware | |
CyDex Pharmaceuticals, Inc. | Delaware | |
Open Monoclonal Technology, Inc. | Delaware | |
OMT I, Inc. | Delaware | |
OMT I, Inc. | Delaware |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.